
Work Package 1
CVD Burden & Inequality
WP1 is a cross-cutting work package that engages cities, citizens, community leaders, municipalities, and health and policy stakeholders. Through co-production, it defines priorities for all other WPs, focusing on how urban inequalities drive cardiovascular disease and identifying practical solutions for prevention and improved population health.
Leaders
Work Package 1 is co-led by the World Health Organization and Novartis with support from the University Medical Centre Utrecht and Menarini.

Kira Fortune
WHO

Sushant Anand
Novartis

Sanne Peters
UMC Utrecht

Andrea Forgione
Menarini
Objectives
1
Understand the burden of urban CVD in relation to health inequalities at the city level.
2
Identify targetable barriers to reducing CVD burden and health inequalities in co-creation with underserved communities.
3
Leverage existing and new composite data to better evaluate indices of obesity, hypertension, dyslipidaemia and diabetes, and their related health inequalities.
Dyslipidemia is a metabolic disorder characterized by abnormally high or low amounts of any or all lipids (fats, triglycerides, cholesterol, phospholipids) or lipoproteins in the blood.





